Ultrasound in CSA patients: Retro US cohort 110pts 28.2% w/ 💥Power Doppler synovitis. 36.8% at 6mo evolved to RA among which 100% PD+ vs 25% PD- PD + predicts evolution to clinical RA (OR 13.1; CI 1.07-161.04) Easier and less invasive than MRI! #Abstr1525 #ACR21 @RheumNow https://t.co/MkhWTvnv3L

#ACR21 Abs#0819. RheumTAP real-world cohort of pts tapering Rx in remission on RA ▶️ Pts tapering 7.6x ⬆️ likely to flare in f/u Great convo soon on @Rheumnow re: tapering studies. @davidliew asks how many more times do we need to see drug w/d fail? https://t.co/BiZSM7yp7o https://t.co/iDXGVpFZzB

• https://bit.ly/3wvjwJB

Abst 0789 Baker & colleagues examined adipokine levels in association with disease activity in RA patients - Patients with high levels of adipokines less likely to achieve low disease activity & remission - These patients more likely to escalate to b/tsDMARDs #ACR21 @RheumNow https://t.co/1xlO4W9q9v

Another exciting day at #ACR21 and covering for @RheumNow Also presented my poster (Abstr 0587) DMARD Use in Medicare Patients with #RheumatoidArthritis and Risk of Long-Term Opioid Use - DMARD users showed lower odds of long term opioid use compared to non-DMARD users https://t.co/2XZgYY8ORg

We know we're all not as great at treat-to-target in RA as we should be. If we want to get fit, we join a group class. If we want to study, we join a study group. Why not the same with TTT, to motivate us to our best? Virtual learning collaboratives 👏 #ACR21 ABST0815 @RheumNow https://t.co/siVOyKjPNx

Dr. R Thomas note that even if you have RA, it's not too late to improve your lifestyle to be healthier. This will help with the mgment of the dz. 2/2 @rheumnow #ACR21